{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T22:01:07Z","timestamp":1789509667671,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T00:00:00Z","timestamp":1631664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Key science and technology plan project of Henan province","award":["162102310198"],"award-info":[{"award-number":["162102310198"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The main objective of this study is to analyze the clinical and pathological features and prognosis of patients with Hepatitis B associated membranous nephropathy (HBV-MN) and idiopathic membranous nephropathy (IMN) complicated with hepatitis B virus (HBV) infection. This study will provide more basis for diagnosis and prognosis evaluation. A total of 50 patients with HBV-MN were included in this study. 56 IMN patients complicated with HBV infection diagnosed during the same period formed the control group. Parameters including blood routine, urine routine and plasma levels of albumin (ALB), serum creatinine (SCR), blood urea nitrogen (BUN), urea acid (UA), total cholesterol (T-CHO), triglycerides (TG), complement C3 and C4, glutamic pyruvic transaminase (ALT), glutamic pyruvic transaminase (AST), 24-h urinary protein quantification (24\u00a0h-TP), renal phospholipase A2 receptor (PLA<jats:sub>2<\/jats:sub>R) and HBV related markers during the hospitalization and outpatient follow-up study period were collected for all the patients. The proportion of male patients was high in both groups. The average age of the HBV-MN group was 37.2\u2009\u00b1\u200914.187\u00a0years old, it was younger compared with the IMN group (<jats:italic>P<\/jats:italic>\u2009=\u20090.003). Nephrotic syndrome was the major clinical manifestation among patients. There was no significant difference between the two groups in the levels of anemia, microscopic hematuria, renal dysfunction, liver dysfunction, liver cirrhosis. The level of serum C3 and C4 in the HBV-MN group was lower compared with the IMN group (<jats:italic>P<\/jats:italic>\u2009=\u20090.002, <jats:italic>P<\/jats:italic>\u2009=\u20090.014). In the HBV-MN group, serum HBV markers were negative in 6 (12%) patients, 4 patients (8%) were positive for PLA<jats:sub>2<\/jats:sub>R in serum, and 5 patients (10%) were positive for PLA<jats:sub>2<\/jats:sub>R in renal tissue. Stronger IgG1 and C1q and weaker IgG4 staining were found in HBV-MN group renal tissues (<jats:italic>P<\/jats:italic>\u2009=\u20090.003, <jats:italic>P<\/jats:italic>\u2009=\u20090.025, and <jats:italic>P<\/jats:italic>\u2009=\u20090.001, respectively). There were no statistical differences compared with serum and renal PLA<jats:sub>2<\/jats:sub>R between HBV-MN and IMN groups (<jats:italic>P<\/jats:italic>\u2009=\u20090.098, <jats:italic>P<\/jats:italic>\u2009=\u20090.109). During the 1-year follow-up, there was no significant difference in complete remission rate between the two groups (<jats:italic>P<\/jats:italic>\u2009=\u20090.7739). Renal biopsy is crucial to diagnose HBV-MN. IgG subtypes in the HBV-MN group were mainly IgG1 deposition, while those in IMN complicated with HBV infection group were mainly IgG4 deposition. When HBV-associated antigen and PLA<jats:sub>2<\/jats:sub>R are present in renal tissue, lower level of serum C3 and C4, high intensity of renal C1q and IgG1 is more supportive of HBV-MN. The positive of PLA<jats:sub>2<\/jats:sub>R in serum and renal tissue in differentiating HBV from IMN complicated with HBV infection remains to be discussed.\n<\/jats:p>","DOI":"10.1038\/s41598-021-98010-y","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T10:03:59Z","timestamp":1631700239000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Clinicopathological characteristics and prognosis of hepatitis B associated membranous nephropathy and idiopathic membranous nephropathy complicated with hepatitis B virus infection"],"prefix":"10.1038","volume":"11","author":[{"given":"Ruiqiang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunqi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongyue","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningning","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,15]]},"reference":[{"key":"98010_CR1","unstructured":"Jue, L., Wannian, L., Wenzhan, J. & Min, L. Bull World Health Organ (3) (2019)."},{"issue":"3","key":"98010_CR2","doi-asserted-by":"publisher","first-page":"230","DOI":"10.2471\/BLT.18.219469","volume":"97","author":"J Liu","year":"2019","unstructured":"Liu, J., Liang, W., Jing, W. & Liu, M. Countdown To 2030: Eliminating hepatitis B disease, China. Bull World Health Organ. 97(3), 230\u2013238 (2019).","journal-title":"Bull World Health Organ."},{"issue":"9","key":"98010_CR3","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.2215\/CJN.09180816","volume":"12","author":"WI Kupin","year":"2017","unstructured":"Kupin, W. I. Viral-associated Gn: Hepatitis B and other viral infections. Clin. J. Am. Soc. Nephrol. 12(9), 1529\u20131533 (2017).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"7718","key":"98010_CR4","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S0140-6736(71)92572-4","volume":"2","author":"B Combes","year":"1971","unstructured":"Combes, B. et al. Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane. Lancet 2(7718), 234\u2013237 (1971).","journal-title":"Lancet"},{"issue":"5","key":"98010_CR5","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1053\/j.ackd.2015.06.003","volume":"22","author":"A Gupta","year":"2015","unstructured":"Gupta, A. & Quigg, R. Glomerular diseases associated with hepatitis B and C. Adv. Chron. Kidney Dis. 22(5), 343\u2013351 (2015).","journal-title":"Adv. Chron. Kidney Dis."},{"issue":"1","key":"98010_CR6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11894-001-0044-1","volume":"3","author":"NT Pyrsopoulos","year":"2001","unstructured":"Pyrsopoulos, N. T. & Reddy, K. R. Extrahepatic manifestations of chronic viral hepatitis. Curr. Gastroenterol. Rep. 3(1), 71\u201378 (2001).","journal-title":"Curr. Gastroenterol. Rep."},{"issue":"2","key":"98010_CR7","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/ki.1990.32","volume":"37","author":"RJ Johnson","year":"1990","unstructured":"Johnson, R. J. & Couser, W. G. Hepatitis B infection and renal disease: Clinical, immunopathogenetic and therapeutic considerations. Kidney Int. 37(2), 663\u2013676 (1990).","journal-title":"Kidney Int."},{"issue":"Pt 1","key":"98010_CR8","first-page":"443","volume":"1","author":"J Churg","year":"1973","unstructured":"Churg, J. & Ehrenreich, T. Membranous nephropathy. Perspect. Nephrol. Hypertens. 1(Pt 1), 443\u2013448 (1973).","journal-title":"Perspect. Nephrol. Hypertens."},{"key":"98010_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jcv.2015.02.012","volume":"66","author":"T Liu","year":"2015","unstructured":"Liu, T. et al. Clinical and pathological characteristics of 5 children with Hbv surface antigen (Hbsag)-negative hepatitis B virus-associated glomerulonephritis. J. Clin. Virol. 66, 1\u20135 (2015).","journal-title":"J. Clin. Virol."},{"key":"98010_CR10","unstructured":"Wei, R., Li, P. & Wu, J. et al. Clinicopathological analysis on hepatitis B virus-associated glomerulonephritis in 205 patients. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2010 24(6), 464\u20137."},{"issue":"1","key":"98010_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/MEG.0000000000000236","volume":"27","author":"D Li","year":"2015","unstructured":"Li, D. et al. Hepatitis B virus-associated glomerulonephritis in Hbsag serological-negative patients. Eur. J. Gastroenterol. Hepatol. 27(1), 65\u201369 (2015).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"9","key":"98010_CR12","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1002\/jmv.25214","volume":"90","author":"MDF Xu","year":"2018","unstructured":"Xu, M. D. F. et al. Resolution of Hbv infection occurs sooner than recovery of renal disease in adult serum Hbsag-negative Hbv-associated glomerulonephritis. J. Med. Virol. 90(9), 1503\u20131507 (2018).","journal-title":"J. Med. Virol."},{"issue":"2","key":"98010_CR13","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/hep.510310232","volume":"31","author":"H Marusawa","year":"2000","unstructured":"Marusawa, H. et al. Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen. Hepatology 31(2), 488\u2013495 (2000).","journal-title":"Hepatology"},{"issue":"6","key":"98010_CR14","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/S0168-8278(00)80134-8","volume":"33","author":"J Bl\u00e4ckberg","year":"2000","unstructured":"Bl\u00e4ckberg, J. & Kidd-Ljunggren, K. Occult hepatitis B virus after acute self-limited infection persisting for 30 years without sequence variation. J. Hepatol. 33(6), 992\u2013997 (2000).","journal-title":"J. Hepatol."},{"issue":"2","key":"98010_CR15","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ejim.2010.11.005","volume":"22","author":"G Xu","year":"2011","unstructured":"Xu, G. & Huang, T. Hepatitis B virus-associated glomerular nephritis in East Asia: Progress and challenges. Eur. J. Intern. Med. 22(2), 161\u2013166 (2011).","journal-title":"Eur. J. Intern. Med."},{"issue":"4","key":"98010_CR16","first-page":"286","volume":"103","author":"TC Su","year":"2004","unstructured":"Su, T. C., Lee, Y. T., Cheng, T. J., Chen, H. P. & Wang, J. D. Chronic hepatitis B virus infection and dyslipidemia. J. Formos Med. Assoc. 103(4), 286\u2013291 (2004).","journal-title":"J. Formos Med. Assoc."},{"issue":"5\u20136","key":"98010_CR17","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1159\/000198223","volume":"18","author":"BJ Potter","year":"1978","unstructured":"Potter, B. J., Elias, E., Fayers, P. M. & Jones, E. A. Profiles of serum complement in patients with hepatobiliary diseases. Digestion 18(5\u20136), 371\u2013383 (1978).","journal-title":"Digestion"},{"issue":"6","key":"98010_CR18","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1097\/TP.0b013e31819a6697","volume":"87","author":"S Beckebaum","year":"2009","unstructured":"Beckebaum, S. et al. Predictive factors of outcome in patients transplanted for hepatitis B. Transplantation 87(6), 872\u2013881 (2009).","journal-title":"Transplantation"},{"issue":"3","key":"98010_CR19","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1159\/000185053","volume":"49","author":"LS Milner","year":"1988","unstructured":"Milner, L. S. et al. Biochemical and serological characteristics of children with membranous nephropathy due to hepatitis B virus infection: Correlation with hepatitis B E antigen, hepatitis B DNA and hepatitis D. Nephron 49(3), 184\u2013189 (1988).","journal-title":"Nephron"},{"issue":"2","key":"98010_CR20","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.cld.2004.02.003","volume":"8","author":"SH Han","year":"2004","unstructured":"Han, S. H. Extrahepatic manifestations of chronic hepatitis B. Clin. Liver Dis. 8(2), 403\u2013418 (2004).","journal-title":"Clin. Liver Dis."},{"issue":"10","key":"98010_CR21","first-page":"1064","volume":"41","author":"X Xu","year":"2016","unstructured":"Xu, X. et al. Role of M-type phospholipase A2 receptor and its antibody in hepatitis B virus-associated membranous nephropathy. Zhong Nan Da Xue Xue Bao Yi Xue Ban 41(10), 1064\u20131068 (2016).","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"98010_CR22","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/1743-422X-10-300","volume":"10","author":"Z Diao","year":"2013","unstructured":"Diao, Z., Ding, J., Yin, C., Wang, L. & Liu, W. Purified hepatitis B virus induces human mesangial cell proliferation and extracellular matrix expression in vitro. Virol. J. 10, 300 (2013).","journal-title":"Virol. J."},{"issue":"3","key":"98010_CR23","first-page":"206","volume":"28","author":"W Jiang","year":"2015","unstructured":"Jiang, W. et al. Relationship between serum dna replication, clinicopathological characteristics and prognosis of hepatitis B virus-associated glomerulonephritis with severe proteinuria by lamivudine plus adefovir dipivoxil combination therapy. Biomed. Environ. Sci. 28(3), 206\u2013213 (2015).","journal-title":"Biomed. Environ. Sci."},{"issue":"5","key":"98010_CR24","doi-asserted-by":"publisher","first-page":"E0156263","DOI":"10.1371\/journal.pone.0156263","volume":"11","author":"HR Dong","year":"2016","unstructured":"Dong, H. R. et al. Retrospective study of phospholipase A2 receptor and igg subclasses in glomerular deposits in Chinese patients with membranous nephropathy. PLoS ONE 11(5), E0156263 (2016).","journal-title":"PLoS ONE"},{"issue":"4","key":"98010_CR25","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrneph.2012.35","volume":"8","author":"P Ronco","year":"2012","unstructured":"Ronco, P. & Debiec, H. Pathogenesis of membranous nephropathy: Recent advances and future challenges. Nat. Rev. Nephrol. 8(4), 203\u2013213 (2012).","journal-title":"Nat. Rev. Nephrol."},{"issue":"4\u20135","key":"98010_CR26","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1159\/000431331","volume":"41","author":"Q Xie","year":"2015","unstructured":"Xie, Q. et al. Renal phospholipase A2 receptor in hepatitis B virus-associated membranous nephropathy. Am. J. Nephrol. 41(4\u20135), 345\u2013353 (2015).","journal-title":"Am. J. Nephrol."},{"key":"98010_CR27","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1056\/Nejm197904123001502","volume":"300","author":"Y Takekoshi","year":"1979","unstructured":"Takekoshi, Y. et al. Free, \u201csmall\u201d and igg-associated \u201clarge\u201d hepatitis B E antigen in the serum and glomerular capillary walls of two patients with membranous glomerulonephritis. N. Engl. J. Med. 300, 814\u2013819. https:\/\/doi.org\/10.1056\/Nejm197904123001502 (1979).","journal-title":"N. Engl. J. Med."},{"key":"98010_CR28","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/Ki.1984.178","volume":"26","author":"H Hirose","year":"1984","unstructured":"Hirose, H. et al. Deposition of hepatitis B E antigen in membranous glomerulonephritis: Identification by F(Ab\u2019)2 fragments of monoclonal antibody. Kidney Int. 26, 338\u2013341. https:\/\/doi.org\/10.1038\/Ki.1984.178 (1984).","journal-title":"Kidney Int."},{"key":"98010_CR29","first-page":"28","volume":"23","author":"N Yoshikawa","year":"1985","unstructured":"Yoshikawa, N. et al. Membranous glomerulonephritis associated with hepatitis B antigen in children: A comparison with idiopathic membranous glomerulonephritis. Clin. Nephrol. 23, 28\u201334 (1985).","journal-title":"Clin. Nephrol."},{"key":"98010_CR30","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0272-6386(88)80176-8","volume":"11","author":"S Takeda","year":"1988","unstructured":"Takeda, S. et al. Characteristics of glomerular lesions in hepatitis B virus infection. Am. J. Kidney Dis. 11, 57\u201362. https:\/\/doi.org\/10.1016\/S0272-6386(88)80176-8 (1988).","journal-title":"Am. J. Kidney Dis."},{"issue":"1","key":"98010_CR31","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/liv.13498","volume":"38","author":"S As","year":"2018","unstructured":"As, S. & Dn, A. Spectrum of hepatitis B and renal involvement. Liver Int. 38(1), 23\u201332 (2018).","journal-title":"Liver Int."},{"issue":"3","key":"98010_CR32","first-page":"1593","volume":"8","author":"L Wang","year":"2016","unstructured":"Wang, L. et al. The combination of tacrolimus and entecavir improves the remission of Hbv-associated glomerulonephritis without enhancing viral replication. Am. J. Transl. Res. 8(3), 1593\u20131600 (2016).","journal-title":"Am. J. Transl. Res."},{"issue":"1","key":"98010_CR33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3171\/jns.1976.44.1.0045","volume":"44","author":"RP White","year":"1976","unstructured":"White, R. P., Hagen, A. & Robertson, J. T. Experimental evaluation of the spasmogenicity of dopamine on the basilar artery. J. Neurosurg. 44(1), 45\u201349 (1976).","journal-title":"J. Neurosurg."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98010-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98010-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98010-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T15:44:34Z","timestamp":1670082274000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98010-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,15]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["98010"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-98010-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,15]]},"assertion":[{"value":"17 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"18407"}}